AI brief of an SEC Form 8-K · NorthStrive Acquisition Corp I. (NSAI)

NorthStrive Acquisition Corp I agrees to merge with Nuclea Energy at $350 million value

Neutral Impact 5 of 5 m&a Written later

NorthStrive Acquisition Corp I, a blank check company, signed a business combination agreement on October 30, 2026 with Nuclea Energy Inc., a developer of advanced nuclear technologies. If completed, Nuclea would become a publicly traded company under the Nuclea-X Inc. name, with an implied enterprise value of $350 million subject to adjustments at closing. Closing is expected in the first half of 2027 and depends on shareholder approvals, an effective Form S-4, Nasdaq listing approval, completion of the pending Moltex acquisition, and other conditions.

Key points

  • Business combination agreement dated October 30, 2026; announced November 2, 2026
  • Implied enterprise value for Nuclea of $350 million, subject to closing adjustments; Nuclea shareholders to receive Class A shares valued at $10.00 per share
  • Nuclea shareholders also to receive 5,000,000 each of Class A, Class B and Class C earnout shares, convertible within four years of closing if specified milestones are met
  • Expected to close in the first half of 2027; SPAC deadline to complete a business combination is August 19, 2027

The filing

CompanyNorthStrive Acquisition Corp I. (NSAI)
Form8-K, current report
Filed with the SECNov 2, 2026, 4:01 PM ET
Accession number0001213900-26-114913

Items reported: 1.01 Material Definitive Agreement7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.